Moores Cancer Center at UC San Diego Health names new director
Diane M. Simeone, MD, has been named the new director of Moores Cancer Center at UC San Diego Health.
Simeone — who will succeed Joseph A. Califano III, MD, and assume the role on April 1 — is a pancreatic surgeon and expert in the biology and multidisciplinary treatment of pancreatic neoplasms. She is currently the Laura and Isaac Perlmutter professor of surgery, director of the Pancreatic Cancer Center, and associate director of translational research at Perlmutter Cancer Center at New York University Langone Health, according to a press release.
Simeone previously served as chair of the scientific and medical advisory board of the Pancreatic Cancer Action Network. She is currently an elected member of the National Academy of Medicine and a member of NCI’s Pancreatic Cancer Task Force and NCI’s Cancer Centers Study Section.
“It is an incredible privilege and honor to be chosen to lead UC San Diego Moores Cancer Center in the setting of its world-class patient care and scientific discoveries,” Simeone said in the release. “The opportunity to be able to help guide clinical and scientific innovation, increase access to early therapeutics through clinical trials, and train the next generation of clinicians and researchers is a lifetime opportunity.”
As director, Simeone will serve as the principal investigator for the NCI-sponsored Cancer Center Support Grant and partner with academic and clinical leaders to guide cancer research and care in the health sciences, as well as provide advice and counsel to campus- and university-level committees, chair UC San Diego Moores Cancer Center executive committee, and more.
“Dr. Simeone has driven transformation in cancer care by building a continuum between groundbreaking research and new therapeutic approaches for cancer detection and treatment,” John M. Carethers, MD, vice chancellor for health sciences at University of California San Diego, said in the release. “She brings a wealth of expertise and vision to her new role as director, and we are deeply honored to have her join us.”
Read more about